Kevin Huang
Psychiatry · Phila, PANPI 1831378975
Payments from drug & device makers
Across 297 payments — averaging $46.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- Neurocrine Biosciences, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$842
- plus $3K from 10 others
What the payments were for
- Food & beverage$13,44398%
- Education$2212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 59 | $2,545 |
| Teva Pharmaceuticals USA, Inc. | 44 | $2,301 |
| Otsuka America Pharmaceutical, Inc. | 21 | $1,713 |
| AbbVie(2 entities) | 35 | $1,532 |
| Neurocrine Biosciences, Inc. | 38 | $1,376 |
| E.r. Squibb & Sons, L.L.C. | 16 | $842 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $823 |
| Sunovion Pharmaceuticals Inc. | 29 | $762 |
| Alkermes, Inc. | 19 | $689 |
| Janssen Scientific Affairs, LLC | 5 | $543 |
| Lundbeck LLC | 10 | $193 |
| Acadia Pharmaceuticals Inc | 2 | $125 |
| Corium, LLC | 1 | $122 |
| Avanir Pharmaceuticals, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$1,121
- VRAYLAR$1,057
- ARISTADA$999
- REXULTI$957
- INGREZZA$724
- CAPLYTA$694
- ABILIFY MAINTENA$618
- COBENFY$473
- LYBALVI$458
- Austedo XR$443
- UZEDY$431
- AUSTEDO$385
- ABILIFY ASIMTUFII$370
- ARISTADA INITIO$250
- LATUDA$241
- Azstarys$122
- SPRAVATO$120
- INVEGA TRINZA$115
How this compares
$13,664 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 18 | $664 |
| Olanzapine | 53 | $572 |
| Bupropion XlBupropion Hcl | 17 | $272 |
| Trazodone Hcl | 37 | $220 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $212 |
| Quetiapine Fumarate | 23 | $205 |
| Benztropine Mesylate | 21 | $164 |
| Sertraline Hcl | 24 | $137 |
| Divalproex Sodium | 12 | $130 |
| Risperidone | 27 | $125 |
| Escitalopram Oxalate | 11 | $78 |
| Fluoxetine Hcl | 19 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Phila
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.